gastrointestinal bleeding treatment devices industry size
Medical Equipment

Gastrointestinal Bleeding Treatment Devices Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What are the Key Projections for the CAGR of the Gastrointestinal Bleeding Treatment Devices Market From 2025 to 2034?

There has been robust growth in the market size of devices used for treating gastrointestinal bleeding in the recent past. The market, which was valued at $0.87 billion in 2024, is predicted to expand to $0.93 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. The expansion observed during the historic period can be ascribed to factors such as an aging population, lifestyle habits, developments in healthcare infrastructure, prevalence of gastrointestinal disorders, and advancements in endoscopy.

The market for devices used in treating gastrointestinal bleeding is projected to witness substantial expansion in the upcoming years. The market is expected to reach a value of $1.3 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.9%. This surge during the forecast period is likely due to factors like patient-focused care, amendments in regulations, the rise of telemedicine and remote consultations, an increase in gastrointestinal disorders, and investment in healthcare. Key trends forecasted for this period encompass non-invasive diagnostic technologies, precision medicine, remote monitoring and telehealth, as well as the integration of artificial intelligence and machine learning.

What Drivers Are Shaping the Growth of the gastrointestinal bleeding treatment devices Market?

The observed increase in the occurrence of upper gastrointestinal bleeding is anticipated to fuel the expansion of the market for gastrointestinal bleeding treatment devices through the forecast era. Upper gastrointestinal (GI) bleeding happens in the esophagus, stomach, or upper section of the small intestine. It can be triggered by peptic ulcers, esophagitis, enteritis, gastritis, cancer, and other issues. For instance, the National Institute for Health and Care Excellence reveals that in the UK, the prevalence of acute upper GI bleeding is estimated to be between 84-172 per 100,000 people each year. Moreover, the National Library of Medicine – National Institutes of Health reported in 2023 that in-hospital mortality rates for upper GI bleeds are around 10%. This percentage remains steady for a month after being hospitalized for a GI bleed. In the long run, approximately three years after admission, death rates from all causes climb to nearly 37%.

Get Your Free Sample of the Global Gastrointestinal Bleeding Treatment Devices Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

Who Are the Dominant Players Pushing the Boundaries of the Gastrointestinal Bleeding Treatment Devices Market?

Major companies operating in the gastrointestinal bleeding treatment devices market include:

• CONMED Corporation_x000D_

• Boston Scientific Corporation_x000D_

• Ovesco Endoscopy AG_x000D_

• Olympus Corporation_x000D_

• Cook Medical_x000D_

How Are Market Trends Revolutionizing the Gastrointestinal Bleeding Treatment Devices Industry in Recent Times?

Major players in the gastrointestinal bleeding treatment devices market are focusing their efforts on developing advanced technologies such as the EVIS X1 endoscopy system. This system aims to increase diagnostic precision, improve patient experience, and make clinical processes more efficient. The advanced imagery of the EVIS X1 endoscopy system is designed to enhance diagnostic accuracy and facilitate therapeutic interventions. Its use extends to various medical disciplines, including gastroenterology, pulmonology, and urology. For example, in November 2023, Olympus Corporation, a Japan-based leader in medical and surgical technologies, introduced its innovative next-generation EVIS X1 endoscopy system. This advanced stage of the EVIS X1 endoscopic imaging technology has been designed to improve diagnostic capabilities, increase procedural efficiency, and promote superior clinical outcomes. The introduction of this new iteration amplifies the strengths of its previous version through the integration of state-of-the-art imaging techniques, user-friendly interfaces, and AI support, customised to meet a broad spectrum of medical applications, particularly within gastroenterology and pulmonology.

Get Instant Access to the Global Gastrointestinal Bleeding Treatment Devices Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

What Are the Primary Segments of the Gastrointestinal Bleeding Treatment Devices Market and Their Roles in Growth Dynamics?

The gastrointestinal bleeding treatment devices market covered in this report is segmented –

1) By Product: Endoscopic Thermal Devices, Other Products

2) By GI Tract Division: Upper GI Tract, Lower GI Tract

3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

Subsegments:

1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices

2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices

Which Geographic Areas Are Influencing the Growth of the Gastrointestinal Bleeding Treatment Devices Market?

North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Defining Features of the Gastrointestinal Bleeding Treatment Devices Market?

Gastrointestinal (GI) bleeding is a sign of an illness in which the gastrointestinal system bleeds. The bleeding could occur anywhere in the gastrointestinal system, including the large intestine, anus, esophagus, small intestine, rectum, and stomach.

Browse Through More Similar Reports By The Business Research Company:

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Stem Cell/Cord Blood Banking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Blood Glucose Meters Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: